UBS Group AG

Position in BIO — Bio-Rad Laboratories, Inc.

CIK 1610520 ZURICH, V8

Back to BIO Full portfolio

Position in BIO

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$90,531,154

-$8,251,705 QoQ

Shares Held

308,338

-13.0% QoQ

Ownership

1.15%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#16

of 397 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Common Shares in BIO Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,660,030,787 across 135 Medical Devices names. BIO ranks #10 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	16,352,420	$697,921,281
2	ABT	Abbott Laboratories	7,356,093	$667,491,874
3	SYK	Stryker Corp	1,909,680	$601,243,647
4	MDT	Medtronic plc	5,551,443	$434,289,383
5	DXCM	Dexcom Inc	6,065,779	$408,530,211
6	ZBH	Zimmer Biomet Holdings, Inc.	2,758,615	$237,489,163
7	PEN	Penumbra Inc	703,822	$222,231,795
8	EW	Edwards Lifesciences Corp	2,350,656	$212,640,338

All Filings in BIO

Export CSV

41 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30 BIO-B	$3,854	13	0.0%	Shares	Defined	2026-08-13
2026-06-30	$90,527,300	308,325	-13.0%	Shares	Defined	2026-08-13
2026-03-31 BIO-B	$3,617	13	+62.5%	Shares	Defined	2026-05-05
2026-03-31	$98,779,242	354,365	+63.9%	Shares	Defined	2026-05-05
2025-12-31 BIO-B	—	8	+166.7%	Shares	Defined	2026-01-29
2025-12-31	$65,502,193	216,186	-6.3%	Shares	Defined	2026-01-29
2025-09-30	$64,691,299	230,719	+14.9%	Shares	Defined	2025-11-13
2025-06-30 BIO-B	—	3	+200.0%	Shares	Defined	2025-08-14
2025-06-30	$48,448,366	200,764	-7.8%	Shares	Defined	2025-08-14
2025-03-31 BIO-B	$241	1	0.0%	Shares	Defined	2025-05-13
2025-03-31	$53,007,420	217,636	+174.5%	Shares	Defined	2025-05-13
2024-12-31 BIO-B	$325	1	-97.2%	Shares	Sole	2025-02-14
2024-12-31	$26,046,240	79,286	+171.3%	Shares	Defined	2025-02-14
2024-09-30	$9,778,767	29,227	-44.8%	Shares	Defined	2024-11-14
2024-06-30	$14,450,246	52,910	-0.7%	Shares	Defined	2024-08-14
2024-03-31	$18,435,560	53,302	+50.2%	Shares	Defined	2024-05-13
2023-12-31	$11,461,300	35,496	-11.1%	Shares	Defined	2024-02-09
2023-09-30	$14,311,831	39,927	+26.1%	Shares	Defined	2023-11-09
2023-06-30	$12,004,831	31,665	+76.1%	Shares	Defined	2023-08-11
2023-03-31	$8,612,778	17,980	+32.4%	Shares	Defined	2023-05-12
2022-12-31 BIO-B	—	36	+3500.0%	Shares	Sole	2023-02-08
2022-12-31	$5,709,831	13,579	+115.6%	Shares	Defined	2023-02-08
2022-09-30 BIO-B	—	1	-99.7%	Shares	Sole	2022-11-10
2022-09-30	$2,627,144	6,298	-17.3%	Shares	Defined	2022-11-10
2022-06-30	$3,771,900	7,620	-55.1%	Shares	Defined	2022-08-10
2022-03-31	$9,565,331	16,983	-7.7%	Shares	Defined	2022-05-16
2021-12-31 BIO-B	—	299	+208.2%	Shares	Sole	2022-02-14
2021-12-31	$13,894,929	18,390	-14.2%	Shares	Defined	2022-02-14
2021-09-30 BIO-B	$73,711	97	+259.3%	Shares	Sole	2021-11-15
2021-09-30	$15,988,690	21,434	+13.9%	Shares	Defined	2021-11-15
2021-06-30 BIO-B	$17,280	27	-32.5%	Shares	Sole	2021-08-13
2021-06-30	$12,122,960	18,816	-31.1%	Shares	Defined	2021-08-13
2021-03-31 BIO-B	—	40	-86.8%	Shares	Sole	2021-05-12
2021-03-31	$15,608,932	27,328	+37.6%	Shares	Defined	2021-05-12
2020-12-31	$11,577,186	19,860	-45.3%	Shares	Defined	2021-02-11
2020-09-30 BIO-B	—	303	+45.7%	Shares	Sole	2020-11-12
2020-09-30	$18,699,341	36,277	-34.6%	Shares	Defined	2020-11-12
2020-06-30 BIO-B	$90,889	208	+118.9%	Shares	Sole	2020-07-31
2020-06-30	$25,059,950	55,505	-27.5%	Shares	Defined	2020-07-31
2020-03-31 BIO-B	$33,375	95	—	Shares	Sole	2020-05-01
2020-03-31	$26,829,758	76,534	—	Shares	Defined	2020-05-01
No filing history on record for this holder in this stock.